Clinical Relevance of Biomarkers of Oxidative Stress

Abstract

Significance: Oxidative stress is considered to be an important component of various diseases. A vast number of methods have been developed and used in virtually all diseases to measure the extent and nature of oxidative stress, ranging from oxidation of DNA to proteins, lipids, and free amino acids. Recent Advances: An increased understanding of the biology behind diseases and redox biology has led to more specific and sensitive tools to measure oxidative stress markers, which are very diverse and sometimes very low in abundance. Critical Issues: The literature is very heterogeneous. It is often difficult to draw general conclusions on the significance of oxidative stress biomarkers, as only in a limited proportion of diseases have a range of different biomarkers been used, and different biomarkers have been used to study different diseases. In addition, biomarkers are often measured using nonspecific methods, while specific methodologies are often too sophisticated or laborious for routine clinical use. Future Directions: Several markers of oxidative stress still represent a viable biomarker opportunity for clinical use. However, positive findings with currently used biomarkers still need to be validated in larger sample sizes and compared with current clinical standards to establish them as clinical diagnostics. It is important to realize that oxidative stress is a nuanced phenomenon that is difficult to characterize, and one biomarker is not necessarily better than others. The vast diversity in oxidative stress between diseases and conditions has to be taken into account when selecting the most appropriate biomarker. Antioxid. Redox Signal. 23, 1144–1170.

Incorporating freeze-dried strawberry powder into a high-fat meal does not alter postprandial vascular function or blood markers of cardiovascular disease risk: a randomized controlled trial

“…Our study was limited to a 4-h postprandial period, and it is possible that changes may have occurred at later time points. Malondialdehyde also has limited reliability as a marker of lipid peroxidation (64,65), and more specific and sensitive biomarkers should be used in future studies. Our sample size was consistent with previous studies; however, as is typically the case with postprandial studies, our study may have been underpowered, given the inherent inter-and intraindividual variability in postprandial responses.…”

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

“…Therefore, biomarkers of pathologic ROS formation are based on measuring the traces left by ROS, which are normally terminal oxidation products of cellular molecules, many of them being nonspecific (Frijhoff et al, 2015). On the contrary, activation of NRF2 and subsequent expression of its target genes is an indirect but reliable estimation of the total exposure of the organism to pathologic ROS formation.…”

Oxidised protein metabolism: recent insights

“…Approaches commonly used to detect or quantify protein carbonyls in biological samples have been comprehensively reviewed by Augustyniak et al (2015). The products of oxidative modification to the aromatic amino acid residues in proteins are also widely used as biomarkers of oxidative damage in ageing, inflammation and a range of disease processes involving oxidative stress (Dalle-Donne et al, 2006;Whiteman and Spencer, 2008;Bechtold et al, 2009;Frijhoff et al, 2015). Oxidative modification to the aromatic amino acids produce an array of products depending on the oxidant involved.…”